
Explore why involving patients early in Joint Scientific Consultations is critical to shaping the outcomes measured in clinical trials.

Around 33,000 people in the UK are currently living with multiple myeloma, an incurable type of blood cancer

Tom Cavanaugh has been appointed as Executive Vice President, Worldwide Chairman Innovative Medicine

The resolution comes after plaintiffs were unable to prove that J&J’s talc products caused their ovarian cancer

A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.

Discover why translation alone is not enough in global clinical trials and how expert localisation improves participant understanding, trust and engagement.

Erleada plus hormone therapy significantly improved key short- and long-term clinical outcomes

Plaque psoriasis affects over 125 million people worldwide

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.

First-in-class oral therapy mimics the effects of exercise with broad potential as a novel treatment for muscle-sparing weight loss

The autoimmune disease affects approximately three to five million people globally

There are currently no approved treatments specifically indicated for LS in the US or Europe